Caprion

Accelerating precision medicine™

COVID-19 Clinical Testing

Moving your COVID-19 vaccine programs forward

The current COVID-19 pandemic and the race towards development of new vaccines and therapies reinforce the importance of partnering with experts on the development and validation of assays for clinical trials.

Our expertise

Caprion has decades of infectious diseases experience working with many pharmaceutical and biotech partners for the development of new vaccines and therapies.

Leveraging our multiple cell-based and cell-free platforms to study immune responses and monitor protein biomarkers, our expert scientists can develop and validate assays within a turn-around time aligned with your clinical needs, enabling you to move your programs forward with confidence.

Measure low frequency antigen responses

Our scientists have extensive experience in customizing ELISpot assays to monitor the immune response to your antigens of interest and deploying those in clinical trials. An IFNγ ELISpot assay is readily available for exploratory endpoints and can be validated for secondary and primary endpoints.

We also develop and deploy FluoroSpot assays, allowing the simultaneous investigation of multiple analytes in one well. Our team validated a FluoroSpot assay to simultaneously investigate T-cell secretion of IFNγ and IL-4 in clinical samples.

Human IFNy and IL-4 FluoroSpot


Publication

Understand immune responses by monitoring cytokine production at the single-cell level

We routinely develop and deploys intra-cellular cytokine staining (ICS) assays to characterize antigen-specific responses in clinical samples. Leveraging our long-standing experience in multiparametric flow cytometry, we simultaneously measure intra and cell-surface markers in individual cells and provide a complete profiling of immune cell subsets.

Our solid experience in customizing ICS assays, including careful selection of the best in vitro cellular parameters, will guarantee optimal results.

Publication

Detect clinically relevant biomarkers

At Caprion-HistoGeneX, we have a long history of working on large infectious diseases programs. With our mass spectrometry (MS) platform, we identify and measure host proteins to better characterize the immune response.

Identify and quantify correlates of protection using our two mass spectrometry approaches: unbiased liquid chromatography-coupled tandem mass spectrometry (LC-MS/MS) and multiple reaction monitoring (MRM).

Publication

Ensure business continuity and improve occupational safety with reliable coronavirus disease detection

Lower the risk of COVID-19 spreading at your workplace with a rapid and early identification of asymptomatic and symptomatic individuals infected with the SARS-CoV-2 virus.

More details

For more information, download our brochure

 


Caprion

Accreditations & Certifications

CAP accreditation and CLIA certification

CAP Accredited

Headquarters

+1 514.360.3600
+1 877.776.3443
141 President Kennedy Ave., Suite SB-5658
Montreal, Quebec
CANADA

USA

Primity Bio
48383 Fremont Blvd
Suite 118
Fremont, CA 94538
Tel.: +1 858.229.2529

Serametrix
2235 Farraday Ave,Suite N,
Carlsbad, CA, 92008, USA
Tel: +1 760 652 4060

HistoGeneX
1331 W 75th St #401,
Naperville, IL 60540, USA
Tel: +1 630-473-6655
info@histogenex.com

AUSTRALIA

Serametrix Party Limited
Suite 4/54-60 Briggs Street
Camperdown, NSW, 2050
Australia
+61 2 9168 5908

EUROPE

Caprion Biosciences Inc.
+32 (0) 71 96 23 36
8 rue Adrienne Bolland
6041 Gosselies
BELGIUM

Serametrix
Unit 22, Surrey Technology Centre,
40 Occam Road,
Guildford, Surrey, UK
GU2 7YG
Tel: +44 1483 685599

Antwerp, Belgium
HistoGeneX
Sint-Bavostraat 78
2610 Antwerpen (Wilrijk)
Belgium
Tel: +32 3 50 20 500
Sample Reception: +32 3 50 20 620
Shipments: +32 3 50 20 625

CANADA LAB

201 President Kennedy Ave., Suite PK-3900
Montreal, Quebec
CANADA
+1 514.360.3600
+1 877.776.3443



Follow us

        

Contact

+1 877.776.3443

info@caprion.com